Nektar
Health Care · Immunology & Inflammation Therapeutics
Visa sponsorship
1 ▼ 50%
H-1B filings in 12 months
1
Green card filings
$183k
Median offered salary
Who they sponsor
Statisticians
1
In the register as Nektar Therapeutics, San Francisco, CA (+1 more)
Other sponsors in the same field
TrexBio 
Viridian Therapeutics 
Neutrolis
InCellDx
Alert me
US Department of Labor · latest filing Dec 3, 2025 · Visa details by country
Financials
Est. Annual Revenue
$62.5M
2023
People
Howard Robin
Executive Officer, Director
Sandra Gardiner
Executive Officer
Mark Wilson
Executive Officer
Jonathan Zalevsky
Executive Officer
Robert Chess
Director
Jeffrey Ajer
Director
Diana Brainard
Director
R. Scott Greer
Director
Roy Whitfield
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data
Connections
List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Shared investors
NEAVia a fund
672 portfolio companies
Click a company to open it. Dashed lines are likely connections. The second step of the network is part of the Pro plan.
Owner
Same company
Same group
Likely
News
Nektar Therapeutics to Announce Financial Results for the Third Quarter on Thursday, November 12, 2026, After Close of U.S.-Based Financial Markets
Nektar Therapeutics (Nasdaq: NKTR) will announce its financial results for the third quarter ended September 30, 2026 on Thursday, November 12, 2026, after the close of U.S.-based financial markets. Howard Robin, President and Chief Executive Officer, wil
Read more
Report
Nektar Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
/PRNewswire/ -- Nektar Therapeutics (NASDAQ: NKTR) today announced that, on October 20, 2026, the Organization and Compensation Committee of Nektar
Read more
Report
Report
New Rezpegaldesleukin Data Supporting Long-term Durability and Disease Improvement in Patients with Alopecia Areata and Atopic Dermatitis at EADV Congress 2026
In the news release, New Rezpegaldesleukin Data Supporting Long-term Durability and Disease Improvement in Patients with Alopecia Areata and Atopic Dermatitis...
Read more
Report
New Biomarker Data Presented in a Late Breaking Oral Presentation at EADV Congress 2026 Showing Early Molecular Responses to Rezpegaldesleukin Across Multiple Immune Pathways Dysregulated in Patients with Atopic Dermatitis
/PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) and collaborators at the Icahn School of Medicine at Mount Sinai today announced new results from a...
Read more
Report
Nektar Announces Three Oral Presentations for Rezpegaldesleukin at the European Academy of Dermatology & Venereology (EADV) Congress 2026
Nektar Therapeutics (Nasdaq: NKTR) announced today that data from its Phase 2b studies of rezpegaldesleukin in atopic dermatitis and alopecia areata will be presented in three separate oral presentations at the European Academy of Dermatology & Venereolog
Read more
Report
Nektar Therapeutics (NKTR) Dropped, So What Is Driving Attention Now?
Nektar Therapeutics (NKTR) has drawn fresh attention after recent share price swings, with the stock down 4% over the past day and 21% over the past month on available return data. At a share price of US$57.06, Nektar Therapeutics has swung sharply lower
Read more
Report
Nektar Announces Publication in The Lancet of Positive Phase 2b REZOLVE-AD 16-Week Induction Results of Rezpegaldesleukin in Moderate-to-Severe Atopic Dermatitis
/PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) today announced the publication of peer-reviewed data from the 16-week induction period of REZOLVE-AD, a...
Read more
Report
Nektar Therapeutics Announces Second Quarter 2026 Financial Results
/PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR), a clinical-stage biotechnology company focused on development of novel immunology therapies, today reported...
Read more
Report
Show more news
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
San Francisco
United States
HQ
50-200 est. staff